Market Indices
Sector Heatmap
CANC — Tema Oncology ETF
NasdaqTema Oncology ETF
- O
- 41.36
- H
- 41.42
- L
- 40.84
- V
- 44.88K
CANC — Latest News & Headlines
20 StoriesApple Stock Is Trading Near Record Highs. Can It Climb Further? - global.morningstar.com
Apple Stock Is Trading Near Record Highs. Can It Climb Further? global.morningstar.com
Microsoft shares might be rangebound. Here's how you can still make money - CNBC
Microsoft shares might be rangebound. Here's how you can still make money CNBC
Can you buy Anthropic stock before the IPO? - Saxo
Can you buy Anthropic stock before the IPO? Saxo
Foghorn Stock Sinks as Lilly Scraps Cancer Deal, Forcing 40% Layoffs - Barron's
Foghorn Stock Sinks as Lilly Scraps Cancer Deal, Forcing 40% Layoffs Barron's
The Magnificent Seven Is Roaring Back, Fueled by Meta’s Rally - wsj.com
The Magnificent Seven Is Roaring Back, Fueled by Meta’s Rally wsj.com
How Amazon’s stock can fight off the AI threat and soar 46% - MarketWatch
How Amazon’s stock can fight off the AI threat and soar 46% MarketWatch
AI stock valuations may have peaked. Trivariate Research thinks these shares can keep working - CNBC
AI stock valuations may have peaked. Trivariate Research thinks these shares can keep working CNBC
Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline - Barron's
Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline Barron's
UniCredit Shares Are Up Amid the Bank’s Buying Spree. Can They Climb Higher? - global.morningstar.com
UniCredit Shares Are Up Amid the Bank’s Buying Spree. Can They Climb Higher? global.morningstar.com
Higher interest rates can be scary for stocks — but it's not that simple - CNBC
Higher interest rates can be scary for stocks — but it's not that simple CNBC
The 2 Triggers That Can Help Nvidia Nail a Fresh Stock Milestone - Barron's
The 2 Triggers That Can Help Nvidia Nail a Fresh Stock Milestone Barron's
Software roared back last quarter. Cramer says these stocks can keep climbing - CNBC
Software roared back last quarter. Cramer says these stocks can keep climbing CNBC
Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test. - Barron's
Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test. Barron's
Jim Cramer says these stocks can win even as oil and bond yields squeeze the market - CNBC
Jim Cramer says these stocks can win even as oil and bond yields squeeze the market CNBC
Microsoft’s AI Gains Can Push the Stock Higher. That’s Good News for Software Peers. - Barron's
Microsoft’s AI Gains Can Push the Stock Higher. That’s Good News for Software Peers. Barron's
Nvidia is repurchasing its own shares—what stock buybacks mean for investors - CNBC
Nvidia is repurchasing its own shares—what stock buybacks mean for investors CNBC
2 Big Trump Breakthroughs Can Power Stock Markets Higher - Barron's
2 Big Trump Breakthroughs Can Power Stock Markets Higher Barron's
This Company’s Software Manages Supply Chains for Retailers. Its Stock Can Surge 30%. - Barron's
This Company’s Software Manages Supply Chains for Retailers. Its Stock Can Surge 30%. Barron's
Grail Stock Soars 34% Ahead of Multi-Cancer Blood Test Review From FDA - Barron's
Grail Stock Soars 34% Ahead of Multi-Cancer Blood Test Review From FDA Barron's
Nike Stock Is Down 44%. Why Jefferies Thinks It Can More Than Double. - Barron's
Nike Stock Is Down 44%. Why Jefferies Thinks It Can More Than Double. Barron's